Pyridoxine-dependent epilepsy: Clinical Trials

5 trials for Pyridoxine-dependent epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Pyridoxine-dependent epilepsy: new trials by email Literature Review of Pyridoxine-dependent epilepsy trials Research Report on Pyridoxine-dependent epilepsy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy
VINELAND II - Pyridoxine-Dependent Epilepsy
CompletedUniversity Hospital, Angers302023-12-292026-08-10
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Pembrolizumab, Tadalafil - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 2CompletedUniversity of California, San Diego72020-04-072026-02-12
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients
Lysine Restricted Diet, Pyridoxine - Pyridoxine Dependant Epilepsy
WithdrawnUniversity of British Columbia2013-04-012014-09-30

Narrower conditions

3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (2)  ·  Acidemia, isovaleric (2)  ·  Anemia, Sickle Cell (2)  ·  Argininosuccinic Aciduria (2)  ·  Ataxia with vitamin E deficiency (2)  ·  Basal ganglia disease, biotin-responsive (2)  ·  Beta ketothiolase deficiency (2)  ·  Biotinidase Deficiency (2)  ·  Brown-Vialetto-Van Laere syndrome (2)  ·  Carbamoyl-Phosphate Synthase I Deficiency Disease (2)  ·  Carnitine palmitoyl transferase 1A deficiency (2)  ·  Carnitine palmitoyl transferase 2 deficiency (2)  ·  Carnitine-Acylcarnitine Translocase Deficiency (2)  ·  Citrullinemia (2)

Broader conditions

Digestive System Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Abnormalities, Multiple (2)  ·  Albinism (2)  ·  Amino Acid Metabolism, Inborn Errors (2)  ·  Anemia (2)  ·  Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Arrhythmias, Cardiac (2)  ·  Avitaminosis (2)  ·  Basal Ganglia Diseases (2)

Interventions

Pyridoxine (1)  ·  Tadalafil (1)  ·  pembrolizumab (1)

Sponsors

Centre Hospitalier Universitaire de Liege (1)  ·  RTI International (1)  ·  University Hospital, Angers (1)  ·  University of British Columbia (1)  ·  University of California, San Diego (1)

Countries

United States (3)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Clara van Karnebeek (1)  ·  Curt Scharfe, MD, PhD (1)  ·  Joseph Califano (1)  ·  Laurent Servais (1)  ·  Sylvia Stockler (1)

Results publications

PMID 10519720, PMID 18762976, PMID 30043187, PMID 30671974, PMID 31315600, PMID 33200442, PMID 33748042, PMID 35142618